Literature DB >> 28375976

Advancing Keloid Treatment: A Novel Multimodal Approach to Ear Keloids.

Michael E Jones1, Jennifer McLane, Rachael Adenegan, JoAnne Lee, Christine A Ganzer.   

Abstract

BACKGROUND/
OBJECTIVE: Management of keloids of the pinna, in particular, those located in the helix and antihelix and lobule that occur as complications of ear piercing.
MATERIALS AND METHODS: Retrospective analysis of 49 patients treated with extralesional surgical excision of keloids localized to the ear followed by the application of autologous platelet-rich plasma (PRP) to wound site and postoperative in-office superficial radiation therapy (SRT). Radiation protocol consisted of 1 to 3 fractions, with cumulative dosage ranging from 1,300 to 1,800 cGy. Average follow-up was 24 months to assess for evidence of recurrence and adverse side effects.
RESULTS: Fifty ear keloids were treated with this method, age from 15 to 66 (mean = 32, SD = 16) of which 14 were male and 35 female. Almost 30% (n = 14) of patients acknowledged the source of injury that led to the development of the keloid was ear piercing. Treatment protocol achieved a 94% success rate with 3 patients who reported recurrence.
CONCLUSION: Surgical excision combined with intraoperative PRP, adjuvant postoperative in-office SRT achieved a 94% nonrecurrence rate on follow-up over a 2-year period. Outcomes provide preliminary, albeit, strong evidence to support this multimodal method as a viable alternative in the management of keloids localized to the ear.

Entities:  

Mesh:

Year:  2017        PMID: 28375976     DOI: 10.1097/DSS.0000000000001145

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  9 in total

Review 1.  A Retrospective Registry Study Evaluating the Long-Term Efficacy and Safety of Superficial Radiation Therapy Following Excision of Keloid Scars.

Authors:  Brian Berman; Mark S Nestor; Michael H Gold; David J Goldberg; Eduardo T Weiss; Isabelle Raymond
Journal:  J Clin Aesthet Dermatol       Date:  2020-10-01

Review 2.  Platelet-Rich Plasma: A Comprehensive Review of Emerging Applications in Medical and Aesthetic Dermatology.

Authors:  Christopher White; Allyson Brahs; David Dorton; Kristin Witfill
Journal:  J Clin Aesthet Dermatol       Date:  2021-11

3.  Downregulation of microRNA-31 inhibits proliferation and induces apoptosis by targeting HIF1AN in human keloid.

Authors:  Juan Zhang; Dan Xu; Na Li; Yan Li; Yongjing He; Xingbo Hu; Lechun Lyu; Li He
Journal:  Oncotarget       Date:  2017-08-16

Review 4.  The evidence behind the use of platelet-rich plasma (PRP) in scar management: a literature review.

Authors:  Osaid H Alser; Ioannis Goutos
Journal:  Scars Burn Heal       Date:  2018-11-18

5.  Surgical Excision of Keloids Followed by In-office Superficial Radiation Therapy: Prospective Study Examining Clinical Outcomes.

Authors:  Michael E Jones; Christine A Ganzer; Deanne Bennett; Andrea Finizio
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-05-03

6.  Clinical efficacy of intermittent magnetic pressure therapy for ear keloid treatment after excision.

Authors:  Dongkeun Jun; Donghyeok Shin; Hyungon Choi; Myungchul Lee
Journal:  Arch Craniofac Surg       Date:  2019-12-20

7.  Single-Cell Sequencing Analysis and Weighted Co-Expression Network Analysis Based on Public Databases Identified That TNC Is a Novel Biomarker for Keloid.

Authors:  Jiaheng Xie; Liang Chen; Yuan Cao; Dan Wu; Wenwen Xiong; Kai Zhang; Jingping Shi; Ming Wang
Journal:  Front Immunol       Date:  2021-12-22       Impact factor: 7.561

8.  Effect and Safety Analysis of PRP and Yifu Combined with Ultrapulsed CO2 Lattice Laser in Patients with Sunken Acne Scar.

Authors:  Yuyan Wang; Wei Yu; Jufang Zhang; Jinsheng Li
Journal:  J Healthc Eng       Date:  2022-01-25       Impact factor: 2.682

9.  Galunisertib Exerts Antifibrotic Effects on TGF-β-Induced Fibroproliferative Dermal Fibroblasts.

Authors:  Joshua M Peterson; Jayson W Jay; Ye Wang; Alejandro A Joglar; Anesh Prasai; Alen Palackic; Steven E Wolf; Amina El Ayadi
Journal:  Int J Mol Sci       Date:  2022-06-15       Impact factor: 6.208

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.